← Back to patent-cliff list
TAX-2
Tier C — Watch / tradeTAX-2
Cnrs
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：IFN-γ, Thrombospondin 1, CD47
Indications (approved)：Solid tumour, Thrombosis
Regional status
US
-
EU
Phase II
2026-04-20
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of TAX-2?
Approved indications include: Solid tumour, Thrombosis.
When does the TAX-2 patent expire?
No public expiry year is available for TAX-2 yet; this page updates once verified.
How do I get a quote for TAX-2 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01